Carvedilol, a third-generation β-blocker prevents oxidative stress-induced neuronal death and activates Nrf2/ARE pathway in HT22 cells

Biochemical and Biophysical Research Communications

Volumn 441, Issue 4, 2013, Pages 917-922

  Ouyang, Ying ^a   Chen, Ziwei ^a   Tan, Min ^a,b   Liu, Anmin ^a   Chen, Meihui ^a   Liu, Jun ^a   Pi, Rongbiao ^a   Fang, Jianpei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Carvedilol; Cell death; Heme oxygenase 1; Nuclear factor E2 related factor 2; Oxidative stress

Indexed keywords

CARVEDILOL; GLUTAMIC ACID; GLUTATHIONE; HEME OXYGENASE; HEME OXYGENASE 1; LACTATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HIPPOCAMPUS; HT22 HIPPOCAMPAL CELL; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

CARVEDILOL; CELL DEATH; HEME OXYGENASE-1; NUCLEAR FACTOR E2-RELATED FACTOR 2; OXIDATIVE STRESS;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; CARBAZOLES; CELL LINE; CELL SURVIVAL; GLUTAMIC ACID; HEME OXYGENASE-1; HYDROGEN PEROXIDE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PROPANOLAMINES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84888848944     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.160     Document Type: Article

References (26)

1. Butterfield D.A., Castegna A., Lauderback C.M., Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging 2002, 23:655-664.
2. 2 release at NADH: ubiquinone oxidoreductase (Complex I) in brain mitochondria. Biochem. J. 2007, 406:125-129.
3. Massaad C.A. Neuronal and vascular oxidative stress in Alzheimer's disease. Curr. Neuropharmacol. 2011, 9:662-673.
4. Poon H.F., Calabrese V., Scapagnini G., Butterfield D.A. Free radicals and brain aging. Clin. Geriatr. Med. 2004, 20:329-359.
5. Calkins M.J., Johnson D.A., Townsend J.A., Vargas M.R., Dowell J.A., Williamson T.P., Kraft A.D., Lee J.M., Li J., Johnson J.A. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid. Redox Signal. 2009, 11:497-508.
6. Mulswinkel F.L., Kuiperij H.B. The Nrf2-ARE signaling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders. Curr. Drug Targets: CNS Neurol. Disord. 2005, 4:267-281.
7. Son T.G., Camandola S., Mattson M.P. Hormetic dietary phytochemicals. Neuromolecular Med. 2008, 10:236-246.
8. Savitz S.I., Erhardt J.A., Anthony J.V., Gupta G., Li X., Barone F.C., Rosenbaum D.M. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J. Cereb. Blood Flow Metab. 2000, 20:1197-1204.
9. Yaoita H., Sakabe A., Maehara K., Maruyama Y. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Circulation 2002, 105:975-980.
10. Abreu R.M., Santos D.J., Moreno A.J. Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress. J. Pharmacol. Exp. Ther. 2000, 295:1022-1030.
11. Lysko P.G., Lysko K.A., Yue T.L., Webb C.L., Gu J.L., Feuerstein G. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke 1992, 23:1630-1635.
12. Kumar A., Prakash A., Dogra S. Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats. Pharmacol. Rep. 2011, 63:915-923.
13. Macedo B., Magalhães J., Batista A.R., Saraiva M.J. Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacol. Res. 2010, 62:514-522.
14. Yoshioka T., Iwamoto N., Tsukahara F., Irie K., Urakawa I., Muraki T. Anti-NO action of carvedilol in cell-free system and in vascular endothelial cells. Br. J. Pharmacol. 2000, 129:1530-1535.
15. Oettl K., Greilberger J., Zangger K., Haslinger E., Reibnegger G., Jürgens G. Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity. Biochem. Pharmacol. 2001, 62:241-248.
16. Tan M., Ouyang Y., Jin M., Chen M., Liu P., Chao X., Chen Z., Chen X., Ramassamy C., Gao Y., Pi R. Downregulation of Nrf2/HO-1 pathway and activation of JNK/c-Jun pathway are involved in homocysteic acid-induced cytotoxicity in HT22 cells. Toxicol. Lett. 2013, 223:1-8.
17. Schäfer M., Goodenough S., Moosmann B., Behl C. Inhibition of glycogen synthase kinase 3 beta is involved in the resistance to oxidative stress in neuronal HT22 cells. Brain Res. 2004, 1005:84-89.
18. Jin D.Q., Lim C.S., Hwang J.K., Ha I., Han J.S. Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells. Biochem. Biophys. Res. Commun. 2005, 331:1264-1269.
19. Brubacher J.L., Bols N.C. Chemically de-acetylated 2',7'-dichlorodihydro- fluorescein diacetate as a probe of respiratory burst activity in mononuclear phagocytes. J. Immunol. Methods 2001, 251:81-91.
20. Davis J.B., Maher P. Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 1994, 652:169-173.
21. Nouhi F., Tusi S.K., Abdi A., Khodagholi F. Dietary supplementation with tBHQ, an Nrf2 stabilizer molecule, confers neuroprotection against apoptosis in amyloid β-injected rat. Neurochem. Res. 2011 May, 36(5):870-878.
22. Xie H., Hou S., Jiang J., Sekutowicz M., Kelly J., Bacskai B.J. Rapid cell death is preceded by amyloid plaque-mediated oxidative stress. Proc. Natl. Acad. Sci. USA 2013, 110:7904-7909.
23. Jones B. Neurodegenerative disease: oxidative stress in cells near amyloid plaques linked to neuronal death. Nat. Rev. Neurol. 2013, 9:300.
24. Carreira R.S., Monteiro P., Gon Alves L.M., Providência L.A. Carvedilol: just another beta-blocker or a powerful cardioprotector?. Cardiovasc. Hematol. Disord. Drug Targets 2006, 6:257-266.
25. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
26. Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., Bannai S., Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 2000, 275:16023-16029.